[18F]-DPA-714 PET/CT (Positron Emission Tomography/Computerized Tomography) in Triple Negative Breast Cancers
Status:
Completed
Trial end date:
2021-07-21
Target enrollment:
Participant gender:
Summary
This phase II study is assessing the correlation between M1/M2 macrophage polarization
determined by tumor immunohistochemistry analysis and [18F]DPA-714 PET/CT binding
(qualitative and texture analysis) in patients with operable triple negative breast cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Institut Cancerologie de l'Ouest
Collaborators:
SIRIC ILIAD SIRIC ILIAD : regional consortium led by the health cooperation consortium